A detailed history of Acg Wealth transactions in Checkpoint Therapeutics, Inc. stock. As of the latest transaction made, Acg Wealth holds 12,000 shares of CKPT stock, worth $26,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,000 -0.0%
Holding current value
$26,880
Previous $12,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 07, 2022

BUY
$1.53 - $3.25 $18,360 - $39,000
12,000 New
12,000 $21,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $192M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.